Canada’s biotechnology industry is entering a defining era of scientific innovation, global investment, and clinical excellence. The Leading 10 Canadian Biotech Companies of 2026 report highlights the organizations transforming healthcare through breakthroughs in neuroscience, oncology, autoimmune diseases, regenerative medicine, cardiovascular care, antibody engineering, and AI-enabled drug discovery. Together, these companies have invested more than US$700...
Takeaways: The licensing of Alethia CMV gives Meridian a saliva-based, rapid molecular test for congenital CMV that can be deployed in the hours after birth, shifting detection from delayed or invasive methods to an easy, hospital-friendly workflow and expanding its Canadian molecular diagnostics portfolio. By enabling faster congenital CMV diagnosis in the first days of...
